Market reports, free public health charts and stories on rare diseases, across every category we cover.
Our markets on rare diseases, by category.
Worldwide reports first. Each covers 2024 history, a 2025 base year and forecasts to 2034.
Worldwide · 2024–2034
View report PharmaceuticalsWorldwide · 2024–2034
View report PharmaceuticalsWorldwide · 2024–2034
View report PharmaceuticalsWorldwide · 2024–2034
View report PharmaceuticalsWorldwide · 2024–2034
View report PharmaceuticalsWorldwide · 2024–2034
View report PharmaceuticalsWorldwide · 2024–2034
View report PharmaceuticalsWorldwide · 2024–2034
View report PharmaceuticalsWorldwide · 2024–2034
View reportNamed as key players in the most of these markets.
Roche5 markets here
Sanofi5 markets here
BioMarin4 markets here
Pfizer Inc.4 markets here
Takeda Pharmaceutical Company Ltd4 markets here
Chiesi3 markets here
Novartis AG3 markets here
PTC Therapeutics3 markets here
Vertex Pharmaceuticals3 markets here
Amicus Therapeutics2 markets here
AstraZeneca2 markets here
Biogen Inc2 markets here
Each opens the market's statistics page, with every country we cover.
Healthcare Services
Medical Devices
Pharmaceuticals
Full reports carry researched sizes, forecasts and company profiles. We also build custom studies.
Acuitas market figures are supplied with each full report. Chart data comes from the public sources named on each chart.